9,009 iShares Biotechnology ETF $IBB Shares Acquired by Outlook Wealth Advisors LLC

Outlook Wealth Advisors LLC lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 311.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 11,898 shares of the financial services provider’s stock after purchasing an additional 9,009 shares during the quarter. Outlook Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,505,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. IFP Advisors Inc increased its position in shares of iShares Biotechnology ETF by 39.3% in the second quarter. IFP Advisors Inc now owns 49,988 shares of the financial services provider’s stock worth $9,507,000 after acquiring an additional 14,115 shares in the last quarter. Security National Bank of Sioux City Iowa IA lifted its position in shares of iShares Biotechnology ETF by 31.8% in the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 12,187 shares of the financial services provider’s stock valued at $2,318,000 after acquiring an additional 2,939 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of iShares Biotechnology ETF by 64.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock valued at $19,369,000 after acquiring an additional 39,760 shares in the last quarter. Kestra Advisory Services LLC lifted its position in shares of iShares Biotechnology ETF by 12.2% in the 1st quarter. Kestra Advisory Services LLC now owns 47,461 shares of the financial services provider’s stock valued at $8,014,000 after acquiring an additional 5,155 shares in the last quarter. Finally, NewEdge Advisors LLC boosted its stake in iShares Biotechnology ETF by 33.2% in the 2nd quarter. NewEdge Advisors LLC now owns 19,622 shares of the financial services provider’s stock worth $3,732,000 after purchasing an additional 4,888 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.1%

iShares Biotechnology ETF stock opened at $217.61 on Friday. iShares Biotechnology ETF has a 52 week low of $154.62 and a 52 week high of $222.29. The company has a 50 day moving average price of $208.43 and a 200 day moving average price of $184.81.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were issued a $0.0112 dividend. The ex-dividend date was Tuesday, September 15th. This is a decrease from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.